Cargando…
Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493461/ https://www.ncbi.nlm.nih.gov/pubmed/31069018 http://dx.doi.org/10.18632/oncotarget.26855 |
| _version_ | 1783415194397966336 |
|---|---|
| author | Morán, Teresa Felip, Eudald Bosch-Barrera, Joaquim de Aguirre, Itziar Ramirez, Jose Luis Mesia, Carles Carcereny, Enric Roa, Diana Sais, Elia García, Yolanda Blanco, Remei Sanchez, Silvia Villacorta, Claudia Rosa Queralt, Cristina Velarde, Jose María Rosell, Rafael |
| author_facet | Morán, Teresa Felip, Eudald Bosch-Barrera, Joaquim de Aguirre, Itziar Ramirez, Jose Luis Mesia, Carles Carcereny, Enric Roa, Diana Sais, Elia García, Yolanda Blanco, Remei Sanchez, Silvia Villacorta, Claudia Rosa Queralt, Cristina Velarde, Jose María Rosell, Rafael |
| author_sort | Morán, Teresa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6493461 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64934612019-05-08 Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer Morán, Teresa Felip, Eudald Bosch-Barrera, Joaquim de Aguirre, Itziar Ramirez, Jose Luis Mesia, Carles Carcereny, Enric Roa, Diana Sais, Elia García, Yolanda Blanco, Remei Sanchez, Silvia Villacorta, Claudia Rosa Queralt, Cristina Velarde, Jose María Rosell, Rafael Oncotarget Correction Impact Journals LLC 2019-04-02 /pmc/articles/PMC6493461/ /pubmed/31069018 http://dx.doi.org/10.18632/oncotarget.26855 Text en Copyright: © 2019 Morán et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Morán, Teresa Felip, Eudald Bosch-Barrera, Joaquim de Aguirre, Itziar Ramirez, Jose Luis Mesia, Carles Carcereny, Enric Roa, Diana Sais, Elia García, Yolanda Blanco, Remei Sanchez, Silvia Villacorta, Claudia Rosa Queralt, Cristina Velarde, Jose María Rosell, Rafael Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer |
| title | Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer |
| title_full | Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer |
| title_fullStr | Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer |
| title_full_unstemmed | Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer |
| title_short | Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer |
| title_sort | correction: monitoring egfr-t790m mutation in serum/plasma for prediction of response to third-generation egfr inhibitors in patients with lung cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493461/ https://www.ncbi.nlm.nih.gov/pubmed/31069018 http://dx.doi.org/10.18632/oncotarget.26855 |
| work_keys_str_mv | AT moranteresa correctionmonitoringegfrt790mmutationinserumplasmaforpredictionofresponsetothirdgenerationegfrinhibitorsinpatientswithlungcancer AT felipeudald correctionmonitoringegfrt790mmutationinserumplasmaforpredictionofresponsetothirdgenerationegfrinhibitorsinpatientswithlungcancer AT boschbarrerajoaquim correctionmonitoringegfrt790mmutationinserumplasmaforpredictionofresponsetothirdgenerationegfrinhibitorsinpatientswithlungcancer AT deaguirreitziar correctionmonitoringegfrt790mmutationinserumplasmaforpredictionofresponsetothirdgenerationegfrinhibitorsinpatientswithlungcancer AT ramirezjoseluis correctionmonitoringegfrt790mmutationinserumplasmaforpredictionofresponsetothirdgenerationegfrinhibitorsinpatientswithlungcancer AT mesiacarles correctionmonitoringegfrt790mmutationinserumplasmaforpredictionofresponsetothirdgenerationegfrinhibitorsinpatientswithlungcancer AT carcerenyenric correctionmonitoringegfrt790mmutationinserumplasmaforpredictionofresponsetothirdgenerationegfrinhibitorsinpatientswithlungcancer AT roadiana correctionmonitoringegfrt790mmutationinserumplasmaforpredictionofresponsetothirdgenerationegfrinhibitorsinpatientswithlungcancer AT saiselia correctionmonitoringegfrt790mmutationinserumplasmaforpredictionofresponsetothirdgenerationegfrinhibitorsinpatientswithlungcancer AT garciayolanda correctionmonitoringegfrt790mmutationinserumplasmaforpredictionofresponsetothirdgenerationegfrinhibitorsinpatientswithlungcancer AT blancoremei correctionmonitoringegfrt790mmutationinserumplasmaforpredictionofresponsetothirdgenerationegfrinhibitorsinpatientswithlungcancer AT sanchezsilvia correctionmonitoringegfrt790mmutationinserumplasmaforpredictionofresponsetothirdgenerationegfrinhibitorsinpatientswithlungcancer AT villacortaclaudiarosa correctionmonitoringegfrt790mmutationinserumplasmaforpredictionofresponsetothirdgenerationegfrinhibitorsinpatientswithlungcancer AT queraltcristina correctionmonitoringegfrt790mmutationinserumplasmaforpredictionofresponsetothirdgenerationegfrinhibitorsinpatientswithlungcancer AT velardejosemaria correctionmonitoringegfrt790mmutationinserumplasmaforpredictionofresponsetothirdgenerationegfrinhibitorsinpatientswithlungcancer AT rosellrafael correctionmonitoringegfrt790mmutationinserumplasmaforpredictionofresponsetothirdgenerationegfrinhibitorsinpatientswithlungcancer |